These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16894432)

  • 1. Cholesterol--frequently asked questions.
    Phillips PJ; Phillipov G
    Aust Fam Physician; 2006 Aug; 35(8):595-6. PubMed ID: 16894432
    [No Abstract]   [Full Text] [Related]  

  • 2. Stricter cholesterol guidelines broaden indications for the 'statin' drugs.
    Capriotti T
    Medsurg Nurs; 2003 Feb; 12(1):51-7. PubMed ID: 12619600
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ezetimibe--intestinal cholesterol absorbtion inhibitor].
    Pikto-Pietkiewicz W; Pasierski T
    Kardiol Pol; 2006 Dec; 64(12):1434-41. PubMed ID: 17206545
    [No Abstract]   [Full Text] [Related]  

  • 4. Keeping our eyes on the prize: low density lipoprotein cholesterol.
    de Lemos JA; Khera A
    Am J Cardiol; 2009 Dec; 104(12):1697-8. PubMed ID: 19962478
    [No Abstract]   [Full Text] [Related]  

  • 5. Ask the doctor. I have been taking a statin to bring down my LDL cholesterol, but my HDL is still on the low side. Do I need to worry about my HDL level if my LDL is okay? If so, what should I do?
    Bhatt DL
    Harv Heart Lett; 2014 May; 24(9):2. PubMed ID: 25151665
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of disease: HDL metabolism as a target for novel therapies.
    Rader DJ
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4(2):102-9. PubMed ID: 17245404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and aortic stenosis in the context of ratio of low- to high-density lipoprotein cholesterol.
    Yilmaz MB
    J Am Coll Cardiol; 2007 Jul; 50(3):289-90; author reply 290. PubMed ID: 17631225
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of hypercholesterolemia in patients with metabolic syndrome: how do different statins compare?
    Knopp RH; Paramsothy P
    Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):136-7. PubMed ID: 16932272
    [No Abstract]   [Full Text] [Related]  

  • 9. [HMG-CoA reductase inhibitors].
    Yamamoto A
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():578-86. PubMed ID: 11347135
    [No Abstract]   [Full Text] [Related]  

  • 10. The anti-thrombotic effects of statins.
    Kearney D; Fitzgerald D
    J Am Coll Cardiol; 1999 Apr; 33(5):1305-7. PubMed ID: 10193731
    [No Abstract]   [Full Text] [Related]  

  • 11. Rationale for aggressive lipid lowering: evidence from clinical trials.
    Farmer JA
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):305-9. PubMed ID: 15151477
    [No Abstract]   [Full Text] [Related]  

  • 12. Aggressive lipid reduction provides additional clinical benefit.
    Am J Manag Care; 2002 Jul; Suppl Symposium Reporter():1, 4. PubMed ID: 12608148
    [No Abstract]   [Full Text] [Related]  

  • 13. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].
    Olsson AG; Nilsson PM
    Lakartidningen; 2009 Mar 18-24; 106(12):854-7. PubMed ID: 19452786
    [No Abstract]   [Full Text] [Related]  

  • 14. Achieving lipid goals. A study of outcomes in an NP Clinic.
    Adkins J; Stanley M
    Adv Nurse Pract; 2007 Jun; 15(6):61-2, 64. PubMed ID: 19999011
    [No Abstract]   [Full Text] [Related]  

  • 15. Vascular disease, hypertension, and prevention.
    Lavie CJ
    J Am Coll Cardiol; 2004 Jul; 44(2 Suppl A):19A-22A. PubMed ID: 15261686
    [No Abstract]   [Full Text] [Related]  

  • 16. Cholesterol.
    Harv Mens Health Watch; 2006 Aug; 11(1):2-3. PubMed ID: 17111473
    [No Abstract]   [Full Text] [Related]  

  • 17. Changing face of dyslipidemia therapy.
    Banerjee AK
    Indian Heart J; 2008; 60(3):192-4. PubMed ID: 19240305
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholesterol, lipids, and statins.
    Ballantyne CM
    Tex Heart Inst J; 2005; 32(3):378-9. PubMed ID: 16392223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing statin drug therapy.
    Ramsey LA; Miles AJ
    Adv Nurse Pract; 2002 Mar; 10(3):27-8. PubMed ID: 12418333
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
    Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.